Skip to main content

Table 1 Summary on cases of drug eruption secondary to entecavir

From: “Black box warning” rash with entecavir - case report

Author/Year

Age

Sex

Clinical manifestations

Sites of lesions

Time intervalH

DLST (drug lymphocyte

stimulation test)/skin patch/scratch test

Confirmed by

Histopathology

Sugiura K et al. 2009 [5]

30

Male

Anaphylaxis

Buttock

2 days

Scratch test positive

Not done

Yamada S et al. 2011 [6]

62

Male

Maculopapular rash

Trunk & extremities

7 days

DLST positive

Not done

Jimi Yoon et al. 2013 [8]

65

Female

Granulomatous

Forehead & face

2 months

Patch test negative

Yes

Maiko Taura et al. 2014 [10]

65

Male

Erythematous plaque

Upper limbs

6 months

DLST positive

Yes

Jeong Tae Kim et al. 2014 [7]

45

Male

Maculopapular rash

Back & extremities

1 months

Not done

Yes

Temiz SA et al. 2018 [9]

50

Female

Bullous eruption

Lower limb

7 days

Not done

Yes

Our case 2020

55

Male

Lichenoid erythematous patch

Trunk & extremities

6 weeks

Not done

Yes

  1. H time interval between drug exposure and onset of symptom